An investigational cancer drug that targets tumors caused by mutations in the KRAS gene will be evaluated in phase 2 clinical trials, following promising safety and efficacy results in preli... Read more
Making drugs cheaper doesn’t always require pricey investments. A joint initiative by researchers from TU Eindhoven, the Dutch company Syncom BV and the Antoni van Leeuwenhoek hospital prove... Read more
May even work on melanomas that have resisted treatment An experimental cancer drug works differently than intended and shows significant promise for stopping melanoma and possibly other for... Read more
Stanford University scientists have discovered a single drug that has killed or shrunk every kind of cancer tumor it has been used against — a new anti-cancer weapon that some have described... Read more
“From this work it appears that cisplatin is a promising lead compound for the rational design of ALS treatments,” A long-used anti-cancer drug could be a starting point to devel... Read more
Drug manufacturers should take notice of the huge pent-up demand The pharmaceutical industry has beat a concerted retreat from developing drugs for diseases that affect the brain, sty... Read more
Could end the problem of cancer drugs becoming resistant A BREAKTHROUGH by Welsh scientists could end the problem of cancer drugs becoming resistant to the disease they are designed t... Read more